Beranda › Penyakit Kardiovaskular › North Carolina › Winston-Salem
Uji klinis Penyakit Kardiovaskular di Winston-Salem, NC
14 studi untuk Penyakit Kardiovaskular mencari peserta di lokasi sekitar Winston-Salem (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Menerima pesertaFase 4
- Novant Health Forsyth Medical Center, Winston-Salem
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
Menerima peserta
- Wake Forest University Health Sciences, Winston-Salem
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Menerima pesertaFase 3
- Wake Forest University Health Sciences-Winston-Salem-61707, Winston-Salem
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
Menerima peserta
- Atrium Health Wake Forest Baptist Medical Center, Winston-Salem
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Menerima pesertaFase 3
- Clinical Trial Site, Winston-Salem
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Menerima pesertaFase 3
- Wake Forest University Baptist Medical Center, Winston-Salem
- Wake Forest University Baptist Medical Center, Winston-Salem
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Menerima pesertaFase 4Sukarelawan sehat diterima
- Wake Forest Baptist Hospital-Cardiology, Winston-Salem
- Wake Forest Hospital - Geriatrics, Winston-Salem
Cardiovascular Effects of Very Low Nicotine Content Cigarettes
Menerima pesertaFase awal 1Sukarelawan sehat diterima
- Wake Forest University Health Sciences, Winston-Salem
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Menerima pesertaStudi observasional
- Wake Forest University Health Sciences, Winston-Salem
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Menerima pesertaFase 3
- Research Site, Winston-Salem
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Menerima pesertaFase 3
- Wake Forest University Health Sciences, Winston-Salem
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Menerima pesertaFase 3
- Wake Forest University Baptist Medical Center, Winston-Salem
Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity
Menerima peserta
- Wake Forest University Health Sciences, Winston-Salem
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
Menerima pesertaFase 2
- Wake Forest University Health Sciences, Winston-Salem
Uji klinis Penyakit Kardiovaskular di kota lain
- Boston, MA37 studi
- New York City, NY33 studi
- Washington, DC28 studi
- Houston, TX24 studi
- Dallas, TX23 studi
- Cleveland, OH22 studi
- Atlanta, GA22 studi
- Chicago, IL21 studi
- Philadelphia, PA21 studi
- Pittsburgh, PA20 studi
- St. Louis, MO20 studi
- Nashville, TN18 studi
Studi lain di Winston-Salem
- Kanker (semua jenis)19 studi
- Leukemia Mieloid Akut18 studi
- Mieloma Multipel14 studi
- Kanker Payudara14 studi
- Kanker Paru Non-Sel Kecil12 studi
- PPOK10 studi
- Kanker Ovarium10 studi
- Diabetes Tipe 29 studi
- Sindrom Mielodisplastik9 studi
- Glioblastoma8 studi
- Leukemia Limfositik Kronis8 studi
- Kanker Paru8 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.